| Dr Susan Michelle Andrews, PSYD | |
|
45453 State Road 19, Altoona, FL 32702-9220 | |
| (352) 348-6989 | |
| Not Available |
| Full Name | Dr Susan Michelle Andrews |
|---|---|
| Gender | Female |
| Speciality | Psychologist - School |
| Location | 45453 State Road 19, Altoona, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972199008 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TS0200X | Psychologist - School | SS1453 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Susan Michelle Andrews, PSYD 45453 State Road 19, Altoona, FL 32702-9220 Ph: (352) 348-6989 | Dr Susan Michelle Andrews, PSYD 45453 State Road 19, Altoona, FL 32702-9220 Ph: (352) 348-6989 |
News Archive
A few home visits by a health care specialist to educate children with asthma about basic strategies for earlier symptom recognition and improving medication use can lead to fewer flare-ups and less frequent trips to the ER, according to research from Johns Hopkins Children's Center published in the December issue of Pediatrics.
Researchers from The Ludwig Institute and the University of California, San Diego (UCSD) School of Medicine have discovered that when motor neurons damaged by amyotrophic lateral sclerosis (ALS), or Lou Gehrig?s disease, inappropriately send the wrong signal, immune cells react by killing the messenger.
Evidence from human famines and animal studies suggests that starvation can affect the health of descendants of famished individuals. But how such an acquired trait might be transmitted from one generation to the next has not been clear.
The October issue of the WHO Bulletin features an editorial on the stockpiling oral cholera vaccine, a public health news roundup, a research article on rotavirus mortality in India, and an article examining a "new entity for the negotiation of public procurement prices for patented medicines in Mexico," among others.
Oraya Therapeutics, Inc. announces today that a leading European notified body has granted approval to designate the CE mark to Oraya's IRayTM stereotactic radiotherapy system. Under development since 2007, the IRay is designed specifically to treat diseases of the eye, and the technology enables precise delivery of low energy X-rays for the treatment of wet age-related macular degeneration (AMD).
› Verified 5 days ago